Overview

Occluded Artery Trial (OAT)

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether opening an occluded infarcted artery 3-28 days after an acute myocardial infarction in high-risk asymptomatic patients reduces the composite endpoint of mortality, recurrent myocardial infarction, and hospitalization for class IV congestive heart failure over an average 2.9-year follow-up with extended follow up for an average of six years. Long term follow-up of patients were completed in March 2010. Final collection of all regulatory documentation was completed June 2011.
Phase:
Phase 3
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors
Platelet Aggregation Inhibitors